title: Rapid progression of 'retinoic acid syndrome' in the hypogranular variant of acute promyelocytic leukaemia, despite treatment with dexamethasone and conventional chemotherapy.
authors.affiliation: Department of Haematology, Addenbrookes NHS Trust, Cambridge, UK.
authors.forename: P
authors.initials: P
authors.lastname: Mahendra
authors.forename: K
authors.initials: K
authors.lastname: Harman
authors.forename: M
authors.initials: M
authors.lastname: Phillips
authors.forename: K
authors.initials: K
authors.lastname: Gunning
authors.forename: R E
authors.initials: RE
authors.lastname: Marcus
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000628:therapy; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000209:etiology; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D003907:Dexamethasone / Q000627:therapeutic use*; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications / Q000188:drug therapy*; D007964:Leukocytosis / Q000139:chemically induced*; D006435:Renal Dialysis; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000139:chemically induced* / Q000628:therapy; D013577:Syndrome; D014212:Tretinoin / Q000009:adverse effects*
chemical_list: D003561:Cytarabine; D014212:Tretinoin; D003907:Dexamethasone; D003630:Daunorubicin